U.S. pharma huge copyright scrapped two experimental weight loss products past calendar year—a the moment-every day pill, lotiglipron, because of elevated liver enzymes plus a 2 times-everyday capsule, danuglipron, as a result of sturdy side effects—but CEO Albert Bourla has explained the company is decided to “Engage in and gain” while in